Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-001679
Filing Date
2025-03-07
Accepted
2025-03-07 17:16:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5139
  Complete submission text file 0001950047-25-001679.txt   6553
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-34207 | Film No.: 25721239
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 39 YORKSHIRE DR OAKLAND CA 94618
Business Address
Novack David F (Reporting) CIK: 0001573072 (see all company filings)

Type: 144